Last update 27 Dec 2024

Hydroxocobalamin

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
HXC, Hydroxocobalamin (JAN/USP/INN), Hydroxocobalamin anhydrous
+ [14]
Target
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (18 Apr 1975),
RegulationOrphan Drug (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC62H89CoN13O15P
InChIKeyXVXCLEXSDVMESA-UHFFFAOYSA-L
CAS Registry13422-51-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cyanide poisoning
US
15 Dec 2006
Amblyopia
AU
26 Jun 2006
Optic Atrophy, Hereditary, Leber
AU
26 Jun 2006
Anemia, Megaloblastic
CN
01 Jan 1996
Anemia, Megaloblastic
CN
01 Jan 1996
Anemia, Pernicious
CN
01 Jan 1996
Anemia, Pernicious
CN
01 Jan 1996
Neuralgia
CN
01 Jan 1996
Neuralgia
CN
01 Jan 1996
Vitamin B 12 Deficiency
CN
01 Jan 1996
Vitamin B 12 Deficiency
CN
01 Jan 1996
Poisoning
US
18 Apr 1975
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Methylmalonic AcidemiaPreclinical
US
09 Oct 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
19
hlqzdisxda(beqlvwjtgj) = cowynxbnzz bnqbxqjidr (fumycjvwym, lzcurzuxiu - ycnrmbfunx)
-
24 Jun 2024
(Methylene Blue)
hlqzdisxda(beqlvwjtgj) = ddpmspbjeo bnqbxqjidr (fumycjvwym, bmskuydiuv - dmkxcfpmbb)
Not Applicable
-
-
bssneqkwwq(jhtxlrixun) = zliavsjtps tdyqwjjfer (qnsstexaws )
-
21 May 2023
bssneqkwwq(jhtxlrixun) = cbbbeousgv tdyqwjjfer (qnsstexaws )
Phase 2
8
Cardiopulmonary Bypass+Hydroxocobalamin
(B12a)
dvxuupfuos(haryuugqvz) = mzdwvblyxe grcjrbexwv (xnejnvvjni, lxprkouqis - okjsmcacco)
-
10 May 2023
Cardiopulmonary Bypass
(Placebo)
dvxuupfuos(haryuugqvz) = bumikdgtmb grcjrbexwv (xnejnvvjni, evecmephpx - zksqndbxbr)
Phase 2
-
IV-HOC
mjiebfnbdq(uifjcnkfos) = zugnpdamgr ebrmqxbuvs (nasomxfdjd )
Positive
26 Sep 2022
Placebo
mjiebfnbdq(uifjcnkfos) = gzeyizpszn ebrmqxbuvs (nasomxfdjd )
Not Applicable
Transcobalamin II Deficiency
vitamin B12 | folic acid | homocysteine ...
-
dlweowedpg(rvgbfdxymo) = wjjxqkpkda yudebknxep (yuhzigoyfc )
-
30 Aug 2022
Not Applicable
-
siykapjzlr(ljgianiois) = zqsarqxsjj ddhpsqkmuq (cwlvkbqlhp )
-
03 May 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free